Agenus | AGEN - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
AbbVie USD -6.66B 3.39B 2026-03
Agenus USD -221.22M 49.89M 2026-03
Amgen USD 9.19B 532M 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Celldex Therapeutics USD 456.23M 70.94M 2026-03
CSL USD 18.66B 2.75B 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Glaxosmithkline GBP 17.42B 4.64B 2026-03
Incyte USD 5.62B 455.37M 2026-03
Intrexon USD 43.17M 75.33M 2024-06
J&J USD 81.19B 358M 2026-03
Jiangsu Hengrui CNY 63.63B 2.35B 2026-03
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
MacroGenics USD 21.2M 34.39M 2026-03
Merck EUR 29.74B 1.15B 2026-03
Merck USD 45.88B 6.73B 2026-03
Northwest Biotherapeutics USD -108.65M 8.26M 2025-09
Novartis USD 38.93B 7.2B 2026-03
Novavax USD -144.76M 17.01M 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Veracyte USD 1.34B 34.83M 2026-03